D
Charles River Laboratories International, Inc. CRL
$160.73 $1.991.25% NYSE
Recommendation
Dividend Power Score
Prev Close
$158.74
Volume
166,533
Avg Vol (90D)
901,566
Market Cap
$7.81B
Dividend & Yield
--
52-Week Range
$91.86 - $228.88
P/E (TTM)
--
EPS (TTM)
-$1.56
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?
4/16/2025 - MarketBeat
Here's How Charles River Stock Is Placed Ahead of Q4 Earnings
2/13/2026 - Zacks Investment Research
Charles River Labs Quarterly Resilience Faces Declining Organic Revenue Test
2/13/2026 - Simply Wall St
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
2/12/2026 - Globe Newswire
Notable Two Hundred Day Moving Average Cross - CRL
2/11/2026 - Nasdaq News: Stocks
Notable Two Hundred Day Moving Average Cross - CRL
2/11/2026 - Market News Video
Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for
2/11/2026 - Zacks Investment Research
Thrivent Financial for Lutherans Has $2.31 Million Position in Charles River Laboratories International, Inc. $CRL
2/11/2026 - MarketBeat
1 S&P 500 Stock with Competitive Advantages and 2 We Ignore
2/11/2026 - StockStory Articles
Assessing Charles River Laboratories (CRL) Valuation After Recent Share Price Pullback
2/10/2026 - Simply Wall St
Principal Financial Group Inc. Grows Position in Charles River Laboratories International, Inc. $CRL
2/10/2026 - MarketBeat
Charles River Laboratories International (CRL, $185.7) RSI Indicator left the oversold zone on February 09, 2026
2/10/2026 - Tickeron - Technical Analysis
Canada Post Corp Registered Pension Plan Grows Position in Charles River Laboratories International, Inc. $CRL
2/8/2026 - MarketBeat
Charles River Laboratories International (CRL, $189.21) RSI Indicator left the oversold zone on February 06, 2026
2/7/2026 - Tickeron - Stocks
Charles River Laboratories International (CRL, $183.7) RSI Indicator left the oversold zone on February 05, 2026
2/6/2026 - Tickeron - Technical Analysis
3 Mid-Cap Stocks That Fall Short
2/6/2026 - StockStory Articles
TTM Technologies Larger Than S&P 500 Component Charles River Laboratories International
2/5/2026 - The Online Investor
Zacks Research Has Positive Outlook for CRL Q4 Earnings
2/4/2026 - MarketBeat
Charles River Laboratories International, Inc. $CRL Position Boosted by Van Berkom & Associates Inc.
2/4/2026 - MarketBeat
Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates
2/2/2026 - Zacks Investment Research
Y Intercept Hong Kong Ltd Invests $1.18 Million in Charles River Laboratories International, Inc. $CRL
2/1/2026 - MarketBeat
Reviewing Charles River Laboratories International (NYSE:CRL) & Ascendant Solutions (OTCMKTS:MYDP)
1/31/2026 - Ticker Report
What Charles River Laboratories International (CRL)'s Royalty-Free AAV Plasmid Tie-Up Means For Shareholders
1/28/2026 - Simply Wall St
AE Wealth Management LLC Buys 1,480 Shares of Charles River Laboratories International Inc (CRL)
1/27/2026 - GuruFocus
HCA Healthcare (HCA) Beats Q4 Earnings Estimates
1/27/2026 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$4.02B
EBITDA (TTM)
$881.99M
EBIT (TTM)
$535.25M
Net Income (TTM)
-$82.28M
Balance Sheet
Total Assets (Q)
$7.51B
Total Debt (Q)
$2.63B
Total Liabilities (Q)
$4.06B
Book Value Per Share (Q)
$69.20
Cash Flow
Cash from Operations (TTM)
$749.49M
Cash from Investing (TTM)
-$192.62M
Cash from Financing (TTM)
-$560.74M
Net Change in Cash (TTM)
-$2.42M
Filings
Filing Date
Wednesday, November 5, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
1.18
7-Day Total Return
-20.38%
30-Day Total Return
-19.52%
60-Day Total Return
-1.36%
90-Day Total Return
-8.24%
Year to Date Total Return
-20.69%
1-Year Total Return
4.81%
2-Year Total Return
-27.11%
3-Year Total Return
-36.67%
5-Year Total Return
-44.01%
52-week Low
Apr 11, 2025 - $91.86
52-week High
Jan 13, 2026 - $228.88
Valuation
Market Cap
$7.81B - Mid Cap
Enterprise Value
$10.28B
Price/Sales (TTM)
1.95
Price/Book (Q)
2.29
Dividends and Shares
Shares Outstanding
49.43M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.criver.com
Phone Number
781 222 6000
Address
251 Ballardvale Street
Wilmington, MA 01887
Country
United States
Year Founded
1947
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and... more
NYSE 02/13/2026 11:26AM Eastern Quotes delayed